Summary: Termination of pregnancy was attempted with intravenous infusion of prostaglandin E2 (5 ug./minute) in 52 consecutive cases. Abortion was successful in 50 of these and complete in 43. There were no serious side-effects.
Introduction
The stimulant action of different prostaglandins on the intact pregnant human uterus has been shown by several investigators (Bygdeman et al., 1968; Embrey, 1969) . Prostaglandins E2 and F2a have been successfully used for the induction of labour in women at or near term (Karim, 1969a (Karim, , 1969b Karim et al., 1969 Karim et al., , 1970a . Prostaglandin F2a in higher concentrations (50 ,ug./minute) has also been used to stimulate the uterus in the first and second trimesters of pregnancy to induce therapeutic abortion (Karim and Filshie, 1970) . In this paper we describe the effects of an intravenous infusion of 5 ,ug. of prostaglandin E2 per minute on the early and midpregnant uterus in 52 women and its usefulness for therapeutic termination of pregnancy in the first and second trimesters.
Patients and Methods Fifty-two patients recommended for therapeutic abortion were treated with prostaglandin E2 infusion at Mulago Hospital, Kampala, Uganda, and at King's College Hospital, London. Their ages ranged from 13 to 40 years. Twenty-three (44%) were nulliparous. The gestation varied from 9 to 22 weeks. In 30 cases (all over 14 weeks' gestation) uterine activity was continuously monitored, and these patients were prepared as follows. The patient was given 100 mg. of pethidine and 50 mg. of promazine (Sparine). One hour later the bladder was catheterized and emptied. The (Fig. 1) . In a few cases the tone of the uterus remained raised by 10-25 mm. Hg throughout the infusion period. In these cases uterine contractions were superimposed on the hypertonus (Fig. 2) . With continuing infusion the contractions became stronger and abortion followed.
Failed Abortions.-In two women (Cases 6 and 25) infusion of S ,ug. of prostaglandin E2 per minute failed to produce an abortion. One was nulliparous and the other a primigravida. Both were in the first trimester of pregnancy (10 and 12 weeks' gestation, respectively). Prostaglandin infused for 42 and 48 hours, respectively, failed to dilate the cervix and produce an abortion despite strong contractions throughout the infusion period. Pregnancy in these two cases was terminated by the suction method. 
MEDICAL
tion. The vaginal operation of therapeutic abortion is fraught with several hazards, including perforation of the uterus, haemorrhage, infection, and cervical incompetence as a result of stretching of muscles of the cervix. The likelihood of these complications increases sharply after the twelfth week, and the procedure is not usually employed after this. After 12 weeks pregnancy is usually terminated by abdominal hysterotomy. This is not an ideal solution and is associated with an operative and postoperative risk (Diggory et al., 1970) . Further, the presence of a scar in the uterus may in future pregnancies render caesarean section the only safe way of delivery.
Other methods used for therapeutic termination of pregnancy include the intra-amniotic injections of hypertonic saline or the instillation of abortifacient paste between membranes and the uterine wall. The former technique is usually employed after 14 weeks and, though usually successful, needs skill and experience. Recently, however, there have been disquieting reports of several deaths following the intraamniotic injections of hypertonic saline (Wagatsuma, 1965; Cameron and Dayan, 1966; Sabeti and de Watteville, 1967; Frost, 1968; Diggory et al., 1970) . The abortifacient paste can be used in early and mid-pregnancy (Lachelin and Burgess, 1968) , but is not free from risk, and sudden death from embolism or vagal inhibition has been reported (Dutra et al., 1950; Williams et al., 1955; Karim and Filshie, 1970) . Hence therapeutic abortion is not a simple operation, and no method of terminating pregnancy before term is entirely devoid of risk. A simple, safe, and effective method for the management of therapeutic abortion is highly desirable.
Medical induction seems to be a more desirable approach to the problem. In this paper we report the use of prostaglandin E2 infusion for therapeutic termination of pregnancy. The safety of the infusion and the optimum concentration required for therapeutic abortion have been determined (Karim et al., 1970b) . According to these authors, a concentration of less than 1 ,ug./minute can stimulate the uterus in the middle trimester of pregnancy. Nevertheless 5 ,ug./minute is the optimum concentration needed to produce contractions of sufficient strength and frequency to dilate the cervix and produce abortion. An infusion of up to 40 ,ug./minute in normal male volunteers has been shown to have no effect on the cardiovascular system, nor does it produce any subjective side-effects (Karim et al., 1970b) .
We have previously reported the use of prostaglandin F2a
(50 ,tg./minute) for therapeutic termination of pregnancy in the first and second trimester of pregnancy (Karim et al., 1970a) . Prostaglandin E2 is also effective over the same gestational period at one-tenth of the concentration. In the prostaglandin E series only four patients out of 52 had diarrhoea compared with about 50% incidence in the prostaglandin F2a group. This suggests a more selective action of prostaglandin E2 on the uterus and less effect on the smooth muscle of the gastrointestinal tract compared with prostaglandin F2a. The reduced incidence of diarrhoea, apart from adding to the comfort of the patient, reduces contamination of the perineum during abortion. The uterine activity produced by prostaglandin E2 in the first and second trimesters of pregnancy is different from the prostaglandin-induced activity at or near term. On the uterus at or near term prostaglandin E2 in a concentration of 0-5-6 ,ug./minute produces normal labour-like contractions with increase in frequency and amplitude (Embrey, 1969; Karim, 1969b , Karim et al., 1970a . The tone of the uterus does not increase. In the first and second trimesters of pregnancy prostaglandin E2 5 ug./minute produces in the uterus an increase in tone as well as frequency and amplitude. Apart from vomiting and diarrhoea, the only other sideeffect was blurring of vision during prostaglandin E2 infusion reported by one patient. Whether this was caused by the drug is difficult to assess. No such effect has been reported with an infusion of up to 40 jig. of prostaglandin E2 per minute in non-pregnant volunteers (Karim et al., 1970b) .
The results of the present series are encouraging. Medical induction of abortion with prostaglandin E2 appears to be effective even in the first trimester of pregnancy. It is simple and safe, eliminating many of the hazards encountered with other methods used. A large proportion of abortions were complete, needing no further surgical intervention.
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